Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-18

Clinical Trial Update: Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia [NA]

View source ↗

Summary

This ongoing pediatric trial is evaluating aerosol peginterferon alfa-2b for respiratory syncytial virus pneumonia, with participant recruitment currently under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peginterferon alfa-2b (Peginterferon alfa-2b)

Snippet

Sponsor: West China Second University Hospital | Conditions: Respiratory Syncytial Virus (RSV) | NA | Status: RECRUITING